Thursday, 10 Jun 2021 | Funding Deadline
To address the need for better treatments for people with MND, the MND Association has joined forces with LifeArc to create a £1 million joint fund aimed at accelerating promising, translational research projects from across the UK and Republic of Ireland in order to develop new treatments or repurpose existing treatments for MND.
The joint funding scheme invites applications for treatment-focused, milestone-driven medical research projects that are on the translational pathway. The hope is that research jointly funded by MND Association and LifeArc will generate valuable outcomes that can secure follow-on funding (additional translational funding or partnering with/licensing to industry) to support continued development of a therapy for MND and progression towards clinical trials.
Deadline for proposals: 10 June 2021
Find out more here